{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:04:38Z","timestamp":1784966678728,"version":"3.55.0"},"reference-count":32,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,8,16]],"date-time":"2008-08-16T00:00:00Z","timestamp":1218844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Wheat\u2010based starch hydrolysates such as glucose syrups, dextrose and maltodextrins are found in more than 50% of European processed food. These products contain low amounts of residual gluten and it has been questioned whether they are safe for coeliac disease patients.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To investigate whether coeliac disease patients can safely consume wheat\u2010based starch hydrolysate products.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> This randomized, double\u2010blind, placebo\u2010controlled, prospective follow\u2010up study involved 90 coeliac disease patients in remission randomized to consume glucose syrups, maltodextrins or placebo for 24\u2003weeks. Small bowel mucosal morphology and inflammation, symptoms, coeliac serology and malabsorption laboratory data were evaluated at baseline and at the end of the study.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Daily ingestion of wheat\u2010based starch hydrolysates, glucose syrups and maltodextrins, had no deleterious effect on small\u2010bowel mucosal villous architecture or inflammation in coeliac disease patients when compared to the placebo group. Neither were there any significant differences in gastrointestinal symptoms, serology or malabsorption parameters after 24\u2003weeks.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Wheat\u2010based starch hydrolysates, glucose syrups and maltodextrins did not have harmful effect on coeliac disease patients. Coeliac patients can thus safely continue to consume these products.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03832.x","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T15:32:03Z","timestamp":1223739123000},"page":"1240-1248","source":"Crossref","is-referenced-by-count":17,"title":["Clinical trial: gluten microchallenge with wheat\u2010based starch hydrolysates in coeliac disease patients \u2013 a randomized, double\u2010blind, placebo\u2010controlled study to evaluate safety"],"prefix":"10.1111","volume":"28","author":[{"given":"K.","family":"KAUKINEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"SALMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"COLLIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"HUHTALA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"K\u00c4RJ\u00c4\u2010LAHDENSUU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00c4KI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021687"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.7.960"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01961.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02768.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.1.160"},{"key":"e_1_2_6_7_2","first-page":"303","article-title":"Evaluation of a gliadin\u2010containing gluten\u2010free product in coeliac patients","volume":"39","author":"Ciclitira PJ","year":"1985","journal-title":"Hum Nutr Clin Nutr"},{"key":"e_1_2_6_8_2","first-page":"294","volume-title":"Coeliac Disease: One Hundred Years","author":"Ejderhamn J","year":"1988"},{"key":"e_1_2_6_9_2","first-page":"164","article-title":"Wheat starch\u2010containing gluten\u2010free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long\u2010term follow\u2010up study","volume":"34","author":"Kaukinen K","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01425.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025390"},{"key":"e_1_2_6_12_2","first-page":"83","article-title":"Effects of small amounts of gluten in the diet of coeliac patients","volume":"33","author":"Auricchio S","year":"1991","journal-title":"Panminerva Med"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8223(97)00156-9"},{"key":"e_1_2_6_14_2","first-page":"65","volume-title":"Proceedings of the 18th Meeting Working Group on Prolamin Analysis and Toxicity","author":"Ferre S","year":"2003"},{"key":"e_1_2_6_15_2","unstructured":"Directive 2003\/89\/EC of the European Parliament and the Council of 10 November 2003 amending Directive 2000\/13\/EC as regards indication of the ingredients present in foodstuffs. Available at:http:\/\/eur\u2010lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2003:308:0015:0018:EN:PDF.2003. Last accessed 27 August 2008."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02481-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2003.54"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2004.tb00062.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02621.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03311.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198212000-00012"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07456.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70008-3"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098272"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01535722"},{"key":"e_1_2_6_26_2","first-page":"993","article-title":"Quality of life of adult coeliac patients treated for 10\u2003years","volume":"33","author":"Hallert C","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_27_2","first-page":"105","article-title":"Gluten\u2010free diet and quality of life in patients with screen\u2010detected celiac disease","volume":"5","author":"Mustalahti K","year":"2002","journal-title":"Eff Clin Pract"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0660357"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91837-6"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07284.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","DOI":"10.2903\/j.efsa.2007.488","volume-title":"Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies [NDA] related to a notification from AAC on wheat\u2010based glucose syrups including dextrose pursuant to Article 6, paragraph 11 of Directive 2000\/13\/EC","author":"European Food Safety Authority","year":"2007"},{"key":"e_1_2_6_32_2","unstructured":"Codex Draft Revised Standard for Gluten\u2010free Foods.Draft Revised Codex Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten (at Step 8 of the Procedure). Available at:http:\/\/www.csaceliacs.org\/documents\/CodexStandardforGF.pdf.2007. Last accessed 27 August 2008."},{"key":"e_1_2_6_33_2","unstructured":"Commission Directive 2007\/68\/EC of 27 November 2007 amending Annex IIIa to Directive 2000\/13\/EC of the European Parliament and of the Council as regards certain food ingredients. Available at:http:\/\/eur\u2010lex.europa.eu\/LexUriServ\/site\/en\/oj\/2007\/l_310\/l_31020071128en00110014.pdf.2007. Last accessed 27 August 2008."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03832.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03832.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:06:52Z","timestamp":1697177212000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03832.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,16]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03832.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03832.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,16]]}}}